Continuing Medical Education Article-Skin Treatment: Photodynamic Therapy: Indications and Treatment

Aesthetic Surgery Journal

Volumn 28, Issue 5, 2008, Pages 545-552

  Gold, Michael H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; PROTOPORPHYRIN; SUNSCREEN;

ACNE VULGARIS; ACTINIC KERATOSIS; ARTICLE; CLINICAL TRIAL; DRUG ABSORPTION; ERYTHEMA; EVIDENCE BASED MEDICINE; FOLLICULITIS; HUMAN; HYPERPIGMENTATION; MULTIPLE CYCLE TREATMENT; PATIENT SAFETY; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; PRIORITY JOURNAL; PULSED DYE LASER; REJUVENATION; SEBACEOUS GLAND DISEASE; SEBACEOUS GLAND HYPERPLASIA; SKIN ABRASION; SKIN CANCER; SKIN CARE; SKIN CRUST FORMATION; SKIN DISEASE; SKIN EDEMA; SKIN INJURY; SKIN PROTECTION; SUPPURATIVE HIDRADENITIS; TREATMENT INDICATION; TREATMENT OUTCOME;

ACNE VULGARIS; AMINOLEVULINIC ACID; CLINICAL TRIALS AS TOPIC; HUMANS; KERATOSIS, ACTINIC; PHOTOCHEMOTHERAPY;

EID: 53449085061     PISSN: 1090820X     EISSN: 1527330X     Source Type: Journal    
DOI: 10.1016/j.asj.2008.08.007     Document Type: Article

References (47)

1. Kennedy J.C., Pottier R.H., and Pross D.C. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 6 (1990) 143-148
2. Gold M.H., and Goldman M.P. 5-Aminolevulinic acid photodynamic therapy: where we have been and where we are going. Dermatol Surg 30 (2004) 1077-1084
3. Braathen L.R., Szeimies R.M., Basset-Seguin N., Bissonnette R., Foley P., Pariser D., et al. Guidelines on the use of photodynamic therapy for nonmelanoma skin cancer: an international consensus. International Society for Photodynamic Therapy in Dermatology, 2005. J Am Acad Dermatol 56 (2007) 125-143
4. Szeimies R.M., Landthaler M., and Karrer S. Non-oncologic indications for ALA-PDT. J Dermatolog Treat 13 Suppl 1 (2002) S13-S18
5. Babilas P., Karrer S., Sidoroff A., Landthaler M., and Szeimies R.M. Photodynamic therapy in dermatology-an update. Photodermatol Photoimmunol Photomed 21 (2005) 142-149
6. Jeffes E.W., McCullough J.L., Weinstein G.D., Kaplan R., Glazer S.D., and Taylor J.R. Photodynamic therapy of actinic keratoses with topical aminolevulinic acid hydrochloride and fluorescent blue light. J Am Acad Dermatol 45 (2001) 96-104
7. Jeffes E.W. Levulan: the first approved topical photosensitizer for the treatment of actinic keratosis. J Dermatolog Treat 13 Suppl 1 (2002) S19-S23
8. Alexiades-Armenakas M.R., and Geronemus R.G. Laser-mediated photodynamic therapy of actinic keratoses. Arch Dermatol 139 (2003) 1313-1320
9. Gold M.H. The evolving role of aminolevulinic acid hydrochloride with photodynamic therapy in photoaging. Cutis 69 6 Suppl (2002) 8-13
10. Touma D., Yaar M., Whitehead S., Konnikov N., and Gilchrest B.A. A trial of short incubation, broad-area photodynamic therapy for facial actinic keratoses and diffuse photodamage. Arch Dermatol 140 (2004) 33-40
11. Ruiz-Rodriguez R., Sanz-Sanchez T., and Cordoba S. Photodynamic photorejuvenation. Dermatol Surg 28 (2002) 742-744
12. Gold M.H., Bradshaw V.L., Boring M.M., Bridges T.M., Biron J.A., and Lewis T.L. Treatment of sebaceous gland hyperplasia by photodynamic therapy with 5-aminolevulinic acid and a blue light source or intense pulsed light source. J Drugs Dermatol 3 6 Suppl (2004) S6-S9
13. Goldman M.P., Atkin D., and Kincad S. PDT/ALA in the treatment of actinic damage: real world experience. J Lasers Surg Med 14 Suppl (2002) 24
14. Avram D.K., and Goldman M.P. Effectiveness and safety of ALA-IPL in treating actinic keratoses and photodamage. J Drugs Dermatol 3 1 Suppl (2004) S36-S39
15. Alexiades-Armenakas M.R., and Geronemus R.G. Laser-mediated photodynamic therapy of actinic chelitis. J Drugs Dermatol 3 (2004) 548-551
16. Alster T.S., Tanzi E.L., and Welch E.C. Photorejuvenation of facial skin with topical 20% 5-aminolevulinic acid and intense pulsed light treatment: a split-face comparison study. J Drugs Dermatol 4 (2005) 35-38
17. Key D.J. Aminolevulinic acid-pulsed dye laser photodynamic therapy for the treatment of photoaging. Cosmetic Dermatol 18 (2005) 31-36
18. Marmur E.S., Phelps R., and Goldberg D.J. Ultrastructural changes seen after ALA-IPL photorejuvenation: a pilot study. J Cosmet Laser Ther 7 (2005) 21-24
19. Dover J.S., Bhatia A.C., Stewart B., and Arndt K.A. Topical 5-aminolevulinic acid combined with intense pulsed light in the treatment of photoaging. Arch Dermatol 141 (2005) 1247-1252
20. Gold M.H., Bradshaw V.L., Boring M.M., Bridges T.M., and Biron J.A. Split-face comparison of photodynamic therapy with 5-aminolevulinic acid and intense pulsed light versus intense pulsed light alone for photodamage. Dermatol Surg 32 (2006) 795-801
21. Redbord K.P., and Hanke C.W. Topical photodynamic therapy for dermatologic disorders: results and complications. J Drugs Dermatol 12 (2007) 1197-1202
22. Gold M.H. Pharmacoeconomic analysis of the treatment of multiple actinic keratoses. J Drugs Dermatol 7 (2008) 23-25
23. Tschen E.H., Wong D.S., Pariser D.M., Dunlap F.E., Houlihan A., Ferdon M.B., et al. Photodynamic therapy using aminolaevulinic acid for patients with nonhyperkeratotic actinic keratoses of the face and scalp: phase IV multicentre clinical trial with 12-month follow up. Br J Dermatol 155 (2006) 1262-1269
24. Hongcharu W., Taylor C.R., Chang Y., Aghassi D., Suthamjariya K., and Anderson R.R. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 115 (2000) 183-192
25. Itoh Y., Ninomiya Y., Tajima S., and Ishibashi A. Photodynamic therapy for acne vulgaris with topical 5-aminolevulinic acid. Arch Dermatol 136 (2000) 1093-1095
26. Itoh Y., Ninomiya Y., Tajima S., and Ishibashi A. Photodynamic therapy of acne vulgaris with topical delta-aminolevulinic acid and incoherent light in Japanese patients. Br J Dermatol 144 (2001) 575-579
27. Goldman M.P. Using 5-aminolevulinic acid to treat acne and sebaceous hyperplasia. Cosmetic Dermatol 16 (2003) 57-58
28. Gold M.H. The utilization of ALA-PDT and a new photoclearing device for the treatment of severe inflammatory acne vulgaris-results of an initial clinical trial. J Lasers Surg Med 15 Suppl (2003) 46
29. Goldman M.P., and Boyce S. A single-center study of aminolevulinic acid and 417 nm photodynamic therapy in the treatment of moderate to severe acne vulgaris. J Drugs Dermatol 2 (2003) 393-396
30. Gold M.H., Bradshaw V.L., Borin M.M., Bridges T.M., Biron J.A., and Carter L.N. The use of a novel intense pulsed light and heat source and ALA-PDT in the treatment of moderate to severe inflammatory acne vulgaris. J Drugs Dermatol 3 6 Suppl (2004) S15-S19
31. Taub A.F. Photodynamic therapy for the treatment of acne: a pilot study. J Drugs Dermatol 3 6 Suppl (2004) S10-S14
32. Alexiades-Armenakas M.R. Long pulsed dye laser-mediated photodynamic therapy combined with topical therapy for mild-to-severe comedonal, inflammatory and cystic acne. J Drugs Dermatol 5 (2006) 45-55
33. Miller A., and Van Camp A. Treatment of cane vulgaris with photodynamic therapy: the use of aminolevulinic acid and green light. Cosmetic Dermatol 19 (2006) 624-627
34. Santos A.V., Belo V.G., and Santos G. Effectiveness of photodynamic therapy with topical 5-aminolevulinic acid and intense pulsed light versus intense pulsed light along in the treatment of acne vulgaris: comparative study. Dermatol Surg 31 (2005) 910-915
35. Rojanamatin J., and Choawawanich P. Treatment of inflammatory facial acne vulgaris with intense pulsed light (IPL) and short contact of topical 5-aminolevulinc acid (ALA): a pilot study. Dermatol Surg 32 (2006) 991-997
36. Horio T., Horio O., Miyauchi-Hashimoto H., Ohnuki M., and Isei T. Photodynamic therapy of sebaceous hyperplasia with topical 5-aminolevulinic acid and slide projector. Br J Dermatol 148 (2003) 1274-1276
37. Alster T., and Tanzi E. Photodynamic therapy with topical aminolevulinic acid and pulsed dye laser irradiation for sebaceous hyperplasia. J Drugs Dermatol 2 (2003) 501-504
38. Richey D.F., and Hopson B. Treatment of sebaceous hyperplasia by photodynamic therapy. Cosmetic Dermatol 17 (2004) 525-529
39. Gold M.H., Bradshaw V.L., Boring M.M., Bridges T.M., Biron J.A., and Lewis T.L. Treatment of sebaceous hyperplasia by photodynamic therapy with 5-aminolevulinic acid and a blue light source or intense pulsed light source. J Drugs Dermatol 3 6 Suppl (2004) S6-S9
40. Gold M.H., Bridges T.M., Bradshaw V.L., and Boring M. ALA-PDT and blue light therapy for hidradenitis suppurativa. J Drugs Dermatol 3 1 Suppl (2004) S32-S35
41. Strauss R.M., Pollock B., Stables G.I., Goulden V., and Cunliffe W.J. Photodynamic therapy using aminolevulinic acid does not lead to clinical improvement in hidradenitis suppurativa. Br J Dermatol 152 (2005) 803-804
42. Gold M.H., Bridges T.M., Bradshaw V.L., and Boring M. ALA-PDT and blue light therapy for hidradenitis suppurativa. J Drugs Dermatol 3 1 Suppl (2004) S32-S35
43. Rivard J., and Ozog D. Henry Ford Hospital dermatology experience with Levulan Kerastick and blue light photodynamic therapy. J Drugs Dermatol 5 (2006) 556-561
44. Nestor M.S., Gold M.H., Kauvar A.N., Taub A.F., Geronemus R.G., Ritvo E.C., et al. The use of photodynamic therapy in dermatology: results of a consensus conference. J Drugs Dermatol 5 (2006) 140-154
45. Gold M.H., and Nestor M.S. Current treatments of actinic keratosis. J Drugs Dermatol 5 2 Suppl (2006) 17-25
46. Gold M.H., Biron J.A., Boring M., Bridges T.M., and Bradshaw V.L. Treatment of moderate to severe inflammatory acne vulgaris: photodynamic therapy with 5-aminolevulinic acid and a novel advanced fluorescence technology pulsed light source. J Drugs Dermatol 6 (2007) 319-322
47. Fang J.Y., Lee W.R., Shen S.C., Fang Y.P., and Hu C.H. Enhancement of topical 5-aminolaevulinic acid delivery by erbium: YAG laser and microdermabrasion: a comparison with iontophoresis and electroporation. Br J Dermatol 151 (2004) 132-140